After the Hype, HOPE (and HPS)
some lessons from the Women’s Health Initiative Trial, the Heart Outcomes Prevention Evaluation Study and the Heart Prevention Study
Downloads
Referências
The effect of vitamin E and beta-carotene on the incidence of lung cancer and other cancers in male smokers. The Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study Group. N Engl J Med 1994;330(15):1029-35.
Bradford-Hill A. Statistical Evidence and Inference. In: Principles of Medical Statis- tics. New York: Oxford University Press; 1971.p.309-23.
Koster RW, Dunning AJ. Intramuscular lidocaine for prevention of lethal arrhythmias in the prehospitalization phase of acute myocardial infarction. N Engl J Med 1985;313(18):1105-10.
Lown B. Lidocaine to prevent ventricular fibrillation: easy does it. N Engl J Med 1985;313(18)1154-6.
Horwitz RI, Feinstein AR. Improved observational method for studying therapeutic efficacy. Suggestive evidence that lidocaine prophylaxis prevents death in acute myo- cardial infarction. JAMA 1981;246(21):2455-9.
Teo KK, Yusuf S, Furberg CD. Effects of prophylactic antiarrhythmic drug therapy in acute myocardial infarction. An overview of results from randomized controlled trials. JAMA 1993;270(13):1589-95.
Echt DS, Liebson PR, Mitchell LB, Peters RW, Obias-Manno D, Barker AH, Arensberg D, Baker A, Friedman L, Greene HL. Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial. N Engl J Med 1991;324(12):781-8.
MacMahon S, Collins R, Peto R, Koster RW, Yusuf S. Effects of prophylactic lido- caine in suspected acute myocardial infarction. An overview of results from the randomized, controlled trials. JAMA 1988;260(13)1910-6.
Pradhan AD, Manson JE, Rossouw JE, et al. Inflammatory biomarkers, hormone replacement therapy, and incident coronary heart disease: prospective analysis from the Women’s Health Initiative observational study. JAMA 2002;288(8)980-7.
Ridker PM, Rifai N, Rose L, Buring JE, Cook NR. Comparison of C-Reactive Protein and Low-Density Lipoprotein Cholesterol Levels in the Prediction of First Cardiovas- cular Events. N Engl J Med 2002; 347(20):1557-65.
Yusuf S, Sleight P, Pogue J, et al. Effects of an angiotensin-converting enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Preven- tion Evaluation Study Investigators. N Engl J Med 2000;342(3):145-53.
Lauritsen K, Rune SJ, Bytzer P, et al. Effect of omeprazole and cimetidine on duodenal ulcer. A double-blind comparative trial. N Engl J Med 1985; 312(15):958-61.
Hulley S, Grady D, Bush T, et al. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group. JAMA 1998;280(7)605-13.
Herrington DM, Reboussin DM, Brosnihan KB, et al. Effects of estrogen replacement on the progression of coronary-artery atherosclerosis. N Engl J Med 2000;343(8):522-9.
McClung MR, Geusens P, Miller PD, et al. Effect of risedronate on the risk of hip fracture in elderly women. N Engl J Med 2001;344:333-40.
Maricic M, Adachi JD, Sarkar S, Wu W, Wong M, Harper K. Early effects of raloxifene on clinical vertebral fractures at 12 months in postmenopausal women with osteoporo- sis. Arch Intern Med 2002;162:1140-3.
Bild DE, Bluemke DA, Burke GL, et al. Multi-ethnic study of atherosclerosis: objec- tives and design. Am J Epidemiol 2002;156(9):871-81.
Report from the NAMS Advisory Panel on Postmenopausal Hormone Therapy. The North American Menopause Society. Accessed at www.menopause.org (accessed on November 20, 2002).
Guidelines for Women’s Health Care. 2nd ed. American College of Obstetricians and Gynecologists. Washington, DC: American Coll of Obstetricians and Gynecologists; 2002:130-3, 171-6, 314-8
MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high- risk individuals: a randomised placebo-controlled trial. Lancet 2002;360(9326):7-22.
Stampfer MJ, Hu FB, Manson JE, Rimm EB, Willett WC. Primary Prevention of Coronary Heart Disease in Women through Diet and Lifestyle. N Engl J Med 2000; 343:16-22.
Angell M. Is Academic Medicine for Sale? N Engl J Med 2000; 342:1516-1518.
Downloads
Publicado
Como Citar
Edição
Seção
Licença

Este trabalho está licenciado sob uma licença Creative Commons Attribution 4.0 International License.